z-logo
open-access-imgOpen Access
Anti-Inflammatory and Antiatherogenic Role of BMP Receptor II in Endothelial Cells
Author(s) -
Chan Woo Kim,
Hannah Song,
Sandeep Kumar,
Douglas Nam,
HyukSang Kwon,
Kyung Hwa Chang,
Dong Ju Son,
Dong Won Kang,
Seth A. Brodie,
Daiana Weiss,
J. David Vega,
Noah AlbertsGrill,
Kathy K. Griendling,
W. Robert Taylor,
Hanjoong Jo
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.300287
Subject(s) - inflammation , downregulation and upregulation , receptor , microbiology and biotechnology , endothelium , endothelial dysfunction , proinflammatory cytokine , gene knockdown , biology , medicine , endocrinology , immunology , apoptosis , biochemistry , gene
Atherosclerosis is an inflammatory disease with multiple underlying metabolic and physical risk factors. Bone morphogenic protein 4 (BMP4) expression is increased in endothelium in atherosclerosis-prone regions and is known to induce endothelial inflammation, endothelial dysfunction, and hypertension. BMP actions are mediated by 2 different types of BMP receptors (BMPRI and BMPRII). Here, we show a surprising finding that loss of BMPRII expression causes endothelial inflammation and atherosclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom